Literature DB >> 22652038

Adiponectin is inversely associated with ratio of serum levels of AGEs to sRAGE and vascular inflammation.

Nobuhiro Tahara, Sho-ichi Yamagishi, Atsuko Tahara, Masatoshi Ishibashi, Naofumi Hayabuchi, Masayoshi Takeuchi, Tsutomu Imaizumi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22652038     DOI: 10.1016/j.ijcard.2012.05.015

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  11 in total

1.  THE EFFECT OF ADIPONECTIN VIA REGULATING THE BONE MICROENVIRONMENT OXIDATIVE STRESS ON OSTEOGENESIS IN TYPE 2 DIABETIC RATS.

Authors:  P Qu; Y Li; X Hu; Y Guo; Y Zhu; X Li; J Zhao
Journal:  Acta Endocrinol (Buchar)       Date:  2021 Apr-Jun       Impact factor: 0.877

Review 2.  Role of receptor for advanced glycation end products (RAGE) in liver disease.

Authors:  Sho-ichi Yamagishi; Takanori Matsui
Journal:  Eur J Med Res       Date:  2015-02-11       Impact factor: 2.175

Review 3.  Toxic AGE (TAGE) Theory for the Pathophysiology of the Onset/Progression of NAFLD and ALD.

Authors:  Masayoshi Takeuchi; Jun-Ichi Takino; Akiko Sakasai-Sakai; Takanobu Takata; Mikihiro Tsutsumi
Journal:  Nutrients       Date:  2017-06-20       Impact factor: 5.717

4.  The ratio of AGE to sRAGE independently associated with albuminuria in hypertensive patients.

Authors:  Kuang-Hsing Chiang; Jaw-Wen Chen; Shao-Sung Huang; Hsin-Bang Leu; Shing-Jong Lin; Po-Hsun Huang
Journal:  BMC Endocr Disord       Date:  2018-11-13       Impact factor: 2.763

5.  Indole-4-carboxaldehyde Isolated from Seaweed, Sargassum thunbergii, Attenuates Methylglyoxal-Induced Hepatic Inflammation.

Authors:  Seon-Heui Cha; Yongha Hwang; Soo-Jin Heo; Hee-Sook Jun
Journal:  Mar Drugs       Date:  2019-08-21       Impact factor: 5.118

6.  Advanced glycation end products and their ratio to soluble receptor are associated with limitations in physical functioning only in women: results from the CARLA cohort.

Authors:  Helen Ebert; Maria Elena Lacruz; Alexander Kluttig; Andreas Simm; Karin Halina Greiser; Daniel Tiller; Nadja Kartschmit; Rafael Mikolajczyk
Journal:  BMC Geriatr       Date:  2019-11-04       Impact factor: 3.921

7.  Association between Advanced Glycation End Products, Soluble RAGE Receptor, and Endothelium Dysfunction, Evaluated by Circulating Endothelial Cells and Endothelial Progenitor Cells in Patients with Mild and Resistant Hypertension.

Authors:  Bogna Gryszczyńska; Magdalena Budzyń; Beata Begier-Krasińska; Angelika Osińska; Maciej Boruczkowski; Mariusz Kaczmarek; Alicja Bukowska; Maria Iskra; Magdalena Paulina Kasprzak
Journal:  Int J Mol Sci       Date:  2019-08-13       Impact factor: 5.923

8.  Clinical significance of AGE-RAGE axis in colorectal cancer: associations with glyoxalase-I, adiponectin receptor expression and prognosis.

Authors:  Stratigoula Sakellariou; Paraskevi Fragkou; Georgia Levidou; Antonios N Gargalionis; Christina Piperi; Georgia Dalagiorgou; Christos Adamopoulos; Angelica Saetta; George Agrogiannis; Irini Theohari; Stavros Sougioultzis; Panagiota Tsioli; Ioannis Karavokyros; Nikolaos Tsavaris; Ioannis D Kostakis; Adamantia Zizi-Serbetzoglou; Gerasimos P Vandoros; Efstratios Patsouris; Penelope Korkolopoulou
Journal:  BMC Cancer       Date:  2016-03-01       Impact factor: 4.430

9.  Adiponectin controls the apoptosis and the expression of tight junction proteins in brain endothelial cells through AdipoR1 under beta amyloid toxicity.

Authors:  Juhyun Song; Seong-Min Choi; Daniel J Whitcomb; Byeong C Kim
Journal:  Cell Death Dis       Date:  2017-10-12       Impact factor: 8.469

10.  Selected Atherosclerosis-Related Diseases May Differentially Affect the Relationship between Plasma Advanced Glycation End Products, Receptor sRAGE, and Uric Acid.

Authors:  Bogna Gryszczyńska; Magdalena Budzyń; Dorota Formanowicz; Maria Wanic-Kossowska; Piotr Formanowicz; Wacław Majewski; Maria Iskra; Magdalena P Kasprzak
Journal:  J Clin Med       Date:  2020-05-10       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.